Skip to main navigation Skip to search Skip to main content

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII

  • Diana Crivellari
  • , Marco Bonetti
  • , Monica Castiglione-Gertsch
  • , Richard D. Gelber
  • , Carl Magnus Rudenstam
  • , Beat Thürlimann
  • , Karen N. Price
  • , Alan S. Coates
  • , Christoph Hürny
  • , Jürg Bernhard
  • , Jurij Lindtner
  • , John Collins
  • , Hans Jörg Senn
  • , Franco Cavalli
  • , John Forbes
  • , Anne Gudgeon
  • , Edda Simoncini
  • , Hernan Cortes-Funes
  • , Andrea Veronesi
  • , Martin Fey
  • Aron Goldhirsch

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science